Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will increase funding for (a) the pathology (i) workforce, (ii) estates and (iii) IT infrastructure and (b) pathology disciplines involved in the pathways for cancer patients.

The 2025 Spending Review prioritised health, with record investment in the health and social care system. The Spending Review announced that annual National Health Service day-to-day spending will increase by £29 billion in real terms, a £53 billion cash increase, by 2028/29 compared to 2023/24.

To provide stability and ensure public services and industries have certainty in their funding, the Government has committed to holding a Spending Review every two years. The 2025 Spending Review sets departmental budgets for day-to-day spending up to 2028/29 and for capital for five years, to 2029/30. The envelope for the next Spending Review, due to be held in 2027, will be set in due course.

We will also publish a 10 Year Workforce Plan to ensure the NHS has the right people in the right places, with the right skills to deliver the best care for patients, when they need it.

As part of the £600 million in capital for diagnostics in 2025/26, announced as part of the Spending Review, the NHS is investing in histopathology automation technology, which will speed up pathology test reporting across England, helping to ensure that patients get their diagnoses faster and supporting reductions in elective waiting lists.

We are funding all pathology networks to increase digital capabilities by March 2026. This will reduce unnecessary waits and repeat tests to ensure that patients receive their blood test results sooner. These actions will help improve patient pathways, including for cancer.